Literature DB >> 31485933

Cyanidin-3-O-Glucoside Protects PC12 Cells Against Neuronal Apoptosis Mediated by LPS-Stimulated BV2 Microglial Activation.

Chayanut Kaewmool1, Sasimol Udomruk1, Thanyaluck Phitak1, Peraphan Pothacharoen1, Prachya Kongtawelert2.   

Abstract

Neuroinflammation is a major factor in the pathogenesis of various neurodegenerative diseases. Microglia are resident macrophages that act as key mediators of inflammation in the brain. In response to inflammatory stimuli including lipopolysaccharide (LPS), microglial activation occurs immediately. Overproduction of inflammatory mediators released by activated microglia contributes to neuron damage in neurodegenerative disease. Therefore, identification of a compound that has anti-inflammatory activities and inhibits microglial activation may be an alternative therapeutic approach for the treatment of neurodegenerative diseases. Cyanidin-3-O-glucoside (C3G), a type of anthocyanin, possesses powerful anti-inflammatory activities. In this study, the anti-inflammatory effects of C3G were investigated in LPS-stimulated BV2 microglia. The results indicate that pretreatment with C3G significantly suppresses microglial activation and the production of neurotoxic mediators including nitric oxide (NO), prostaglandin E2 (PGE2), and pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-6 (IL-6) in LPS-activated BV2 cells. Moreover, C3G downregulates the gene expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and pro-inflammatory cytokines via the suppression of NF-κB and p38 MAPK signaling pathways. Furthermore, a co-culture system to determine the indirect neuroprotective effects of C3G was used. Results demonstrated that conditioned medium (CM) from LPS-stimulated BV2 cells can promote the apoptosis of differentiated pheochromocytoma (PC12) cells through the activation of caspase-3, while C3G pretreatment in BV2 microglia can protect differentiated PC12 cells from microglial activation-induced apoptosis. Therefore, C3G may be a potential therapeutic agent for the treatment and prevention of neurodegenerative diseases associated with microglial activation.

Entities:  

Keywords:  Conditioned medium; Cyanidin-3-O-glucoside; Inflammatory mediators; Lipopolysaccharide; Microglia; Neuroinflammation

Year:  2019        PMID: 31485933     DOI: 10.1007/s12640-019-00102-1

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  67 in total

1.  Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways.

Authors:  Xiaolei Shi; Zhenyang Zheng; Jie Li; Zijian Xiao; Weiwei Qi; Aiwu Zhang; Qi Wu; Yannan Fang
Journal:  Neurosci Lett       Date:  2015-03-25       Impact factor: 3.046

2.  Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.

Authors:  Marina Korotkova; Marie Westman; Karina R Gheorghe; Erik af Klint; Christina Trollmo; Ann Kristin Ulfgren; Lars Klareskog; Per-Johan Jakobsson
Journal:  Arthritis Rheum       Date:  2005-11

3.  Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.

Authors:  Liya Qin; Guorong Li; Xun Qian; Yuxin Liu; Xuefei Wu; Bin Liu; Jau-Shyong Hong; Michelle L Block
Journal:  Glia       Date:  2005-10       Impact factor: 7.452

4.  Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain.

Authors:  Séverine Talavéra; Catherine Felgines; Odile Texier; Catherine Besson; Angel Gil-Izquierdo; Jean-Louis Lamaison; Christian Rémésy
Journal:  J Agric Food Chem       Date:  2005-05-18       Impact factor: 5.279

Review 5.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

6.  Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study.

Authors:  Charles Czank; Aedín Cassidy; Qingzhi Zhang; Douglas J Morrison; Tom Preston; Paul A Kroon; Nigel P Botting; Colin D Kay
Journal:  Am J Clin Nutr       Date:  2013-05       Impact factor: 7.045

7.  Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-beta peptide-induced toxicity.

Authors:  Andrea Tarozzi; Adriana Merlicco; Fabiana Morroni; Francesca Franco; Giorgio Cantelli-Forti; Gabriella Teti; Mirella Falconi; Patrizia Hrelia
Journal:  Neuroreport       Date:  2008-10-08       Impact factor: 1.837

8.  Methyl salicylate 2-O-β-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes.

Authors:  Xi Lan; Rui Liu; Lan Sun; Tiantai Zhang; Guanhua Du
Journal:  J Neuroinflammation       Date:  2011-08-11       Impact factor: 8.322

9.  Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.

Authors:  Iva Bozic; Danijela Savic; Danijela Laketa; Ivana Bjelobaba; Ivan Milenkovic; Sanja Pekovic; Nadezda Nedeljkovic; Irena Lavrnja
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

Review 10.  Old Drugs as New Treatments for Neurodegenerative Diseases.

Authors:  Fernando Durães; Madalena Pinto; Emília Sousa
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-11
View more
  10 in total

Review 1.  Therapeutic benefits of flavonoids against neuroinflammation: a systematic review.

Authors:  Ann Maria Alex; Mahalakshmi Arehally Marappa; Suresh Joghee; Saravana Babu Chidambaram
Journal:  Inflammopharmacology       Date:  2022-01-15       Impact factor: 4.473

2.  Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways.

Authors:  Prachya Kongtawelert; Chayanut Kaewmool; Thanyaluck Phitak; Mattabhorn Phimphilai; Peraphan Pothacharoen; Thuzar Hla Shwe
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

3.  Marine Microorganism-Derived Macrolactins Inhibit Inflammatory Mediator Effects in LPS-Induced Macrophage and Microglial Cells by Regulating BACH1 and HO-1/Nrf2 Signals through Inhibition of TLR4 Activation.

Authors:  Eun-Nam Kim; Ming Gao; Hyukjae Choi; Gil-Saeng Jeong
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.411

4.  TRIM45 causes neuronal damage by aggravating microglia-mediated neuroinflammation upon cerebral ischemia and reperfusion injury.

Authors:  Qian Xia; Gaofeng Zhan; Meng Mao; Yin Zhao; Xing Li
Journal:  Exp Mol Med       Date:  2022-02-25       Impact factor: 12.153

Review 5.  Assessing the Nutritional-Value-Based Therapeutic Potentials and Non-Destructive Approaches for Mulberry Fruit Assessment: An Overview.

Authors:  Muhammad Faisal Manzoor; Abid Hussain; Diana Tazeddinova; Aizhan Abylgazinova; Bin Xu
Journal:  Comput Intell Neurosci       Date:  2022-03-24

6.  Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells.

Authors:  Yuan Zhou; Li Chen; Deping Ding; Ziheng Li; Li Cheng; Qiuyun You; Shunbo Zhang
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

7.  Cyanidin-3-O-Glucoside Regulates the M1/M2 Polarization of Microglia via PPARγ and Aβ42 Phagocytosis Through TREM2 in an Alzheimer's Disease Model.

Authors:  Jae-Ho Shin; Miey Park; Hae-Jeung Lee
Journal:  Mol Neurobiol       Date:  2022-06-07       Impact factor: 5.682

Review 8.  Maize Flavonoid Biosynthesis, Regulation, and Human Health Relevance: A Review.

Authors:  Héctor A Peniche-Pavía; Tereso J Guzmán; Jesús M Magaña-Cerino; Carmen M Gurrola-Díaz; Axel Tiessen
Journal:  Molecules       Date:  2022-08-13       Impact factor: 4.927

Review 9.  The Anti-Neuroinflammatory Role of Anthocyanins and Their Metabolites for the Prevention and Treatment of Brain Disorders.

Authors:  Joana F Henriques; Diana Serra; Teresa C P Dinis; Leonor M Almeida
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

10.  Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.

Authors:  Fangling Zhao; Xiang Gao; XiaoJuan Ge; Jiawen Cui; Xia Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.